Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Cancer Res. 2011 Feb 15;71(4):1344-55. doi: 10.1158/0008-5472.CAN-10-2733. Epub 2011 Feb 8.
We evaluated the generalizability of a single nucleotide polymorphism (SNP), rs2046210 (A/G allele), associated with breast cancer risk that was initially identified at 6q25.1 in a genome-wide association study conducted among Chinese women. In a pooled analysis of more than 31,000 women of East-Asian, European, and African ancestry, we found a positive association for rs2046210 and breast cancer risk in Chinese women [ORs (95% CI) = 1.30 (1.22-1.38) and 1.64 (1.50-1.80) for the AG and AA genotypes, respectively, P for trend = 1.54 × 10⁻³⁰], Japanese women [ORs (95% CI) = 1.31 (1.13-1.52) and 1.37 (1.06-1.76), P for trend = 2.51 × 10⁻⁴], and European-ancestry American women [ORs (95% CI) = 1.07 (0.99-1.16) and 1.18 (1.04-1.34), P for trend = 0.0069]. No association with this SNP, however, was observed in African American women [ORs (95% CI) = 0.81 (0.63-1.06) and 0.85 (0.65-1.11) for the AG and AA genotypes, respectively, P for trend = 0.4027]. In vitro functional genomic studies identified a putative functional variant, rs6913578. This SNP is 1,440 bp downstream of rs2046210 and is in high linkage disequilibrium with rs2046210 in Chinese (r(2) = 0.91) and European-ancestry (r² = 0.83) populations, but not in Africans (r² = 0.57). SNP rs6913578 was found to be associated with breast cancer risk in Chinese and European-ancestry American women. After adjusting for rs2046210, the association of rs6913578 with breast cancer risk in African Americans approached borderline significance. Results from this large consortium study confirmed the association of rs2046210 with breast cancer risk among women of Chinese, Japanese, and European ancestry. This association may be explained in part by a putatively functional variant (rs6913578) identified in the region.
我们评估了一个单核苷酸多态性(SNP)rs2046210(A/G 等位基因)的普遍性,该 SNP 最初在一项针对中国女性的全基因组关联研究中在 6q25.1 处被确定与乳腺癌风险相关。在一项超过 31000 名东亚、欧洲和非洲血统的女性的汇总分析中,我们发现 rs2046210 与中国女性的乳腺癌风险呈正相关 [OR(95%CI)=1.30(1.22-1.38)和 1.64(1.50-1.80)分别为 AG 和 AA 基因型,趋势 P 值=1.54×10⁻³⁰]、日本女性 [OR(95%CI)=1.31(1.13-1.52)和 1.37(1.06-1.76),趋势 P 值=2.51×10⁻⁴] 和欧洲裔美国女性 [OR(95%CI)=1.07(0.99-1.16)和 1.18(1.04-1.34),趋势 P 值=0.0069]。然而,在非裔美国女性中,没有观察到与该 SNP 的关联 [OR(95%CI)=0.81(0.63-1.06)和 0.85(0.65-1.11)分别为 AG 和 AA 基因型,趋势 P 值=0.4027]。体外功能基因组研究鉴定出一个假定的功能变体 rs6913578。该 SNP 位于 rs2046210 下游 1440bp,在中国(r²=0.91)和欧洲裔(r²=0.83)人群中与 rs2046210 高度连锁不平衡,但在非洲人(r²=0.57)中则不然。发现 SNP rs6913578 与中国和欧洲裔美国女性的乳腺癌风险相关。在调整 rs2046210 后,rs6913578 与非裔美国人乳腺癌风险的关联接近显著水平。这项由大型联盟研究的结果证实了 rs2046210 与中国、日本和欧洲裔女性乳腺癌风险的关联。这种关联部分可能可以通过在该区域鉴定出的一个假定的功能变体(rs6913578)来解释。